Literature DB >> 34897960

Puerarin alleviates cadmium-induced oxidative damage to bone by reducing autophagy in rats.

Xishuai Tong1,2,3,4, Gengsheng Yu2,3, Qingyang Liu2,3, Xueqing Zhang2,3, Jianchun Bian2,3,4, Zongping Liu1,2,3,4, Jianhong Gu1,2,3,4.   

Abstract

Autophagy is a regulatory mechanism involved in cadmium (Cd)-induced bone toxicity and is suppressed by various stimuli, including oxidative stress. Puerarin is an isoflavonoid compound isolated from Pueraria, a plant used in traditional Chinese medicine. The underlying mechanisms of action of puerarin remain unclear. The objective of this study was to explore the mitigating effects of puerarin on cadmium-induced oxidative damage in the bones of rats. Cadmium exposure increased oxidative damage in rat bones; this was markedly decreased by puerarin treatment, as demonstrated by changes in the activity of antioxidative enzymes. Cadmium-induced blockage of the expression of key bone regulatory proteins, autophagy-related markers, and signaling molecules was also alleviated by puerarin treatment. Additionally, cadmium reduced expression of the autophagic protein Rab7 and of late endosomal/lysosomal adaptor and MAPK and mTOR activator 1 (LAMTOR1); the decrease in these proteins was not restored by puerarin treatment. We speculate that puerarin relieves the inhibition of fusion of autophagosomes with lysosomes that is induced by cadmium; however, this specific effect of puerarin and downstream effects on bone regulatory mechanisms require further investigation. In conclusion, puerarin alleviates cadmium-induced oxidative damage in the bones of rats by attenuating autophagy, which is likely associated with the antioxidant activity of puerarin.
© 2021 Wiley Periodicals LLC.

Entities:  

Keywords:  autophagy; bone; cadmium; osteoclastogenesis; puerarin

Mesh:

Substances:

Year:  2021        PMID: 34897960     DOI: 10.1002/tox.23437

Source DB:  PubMed          Journal:  Environ Toxicol        ISSN: 1520-4081            Impact factor:   4.119


  1 in total

1.  Bergenin alleviates Diabetic Retinopathy in STZ-induced rats.

Authors:  Yu Yin; Ruyi Xu; Lei Ning; Zhimin Yu
Journal:  Appl Biochem Biotechnol       Date:  2022-05-27       Impact factor: 2.926

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.